Advanced Search

Oncology & Hematology Coding Alert

J8561:

Afinitor and Zortress Have a Common Code

Published on Tue Jan 17, 2012

As an oncology coder, you may be interested to know that HCPCS 2012 added J8561 (Everolimus, oral, 0.25 mg), which applies to Afinitor and Zortress. Afinitor is used to treat advanced renal cell carcinoma (RCC) previously treated unsuccessfully with other medications and to treat the brain tumor subependymal giant cell astrocytoma (SEGA) when surgery isn't an option for patients with tuberous sclerosis.Physicians prescribe Zortress with other medications to prevent transplant rejection.Key point: This code is specific to an oral medication sold and reported by pharmacies.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All